Last reviewed · How we verify

NCT06046131: KP-CARAIBES

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Recruiting now NA Last updated 17 November 2025
What this trial tests

NA trial testing Standard care in Prostatic Neoplasm in 3,000 participants. Currently enrolling.

Timeline
28 February 2023
Primary endpoint
28 February 2039
28 February 2039

Quick facts

Lead sponsorCentre Hospitalier Universitaire de la Guadeloupe
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment3,000
Start date28 February 2023
Primary completion28 February 2039
Estimated completion28 February 2039
Sites2 locations across Guadeloupe, France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Who can join

18 and older, male only, with Prostatic Neoplasm or Adenocarcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options. Identifying modifiable and non-modifiable prognostic determinants of disease progression is a major challenge. This knowledge will help guide treatment choices but also, especially in high-risk populations (high incidence of disease) to better tailor prevention policies and possibly screening .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard care

Trials testing the same drug.

Other recruiting trials for Prostatic Neoplasm

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de la Guadeloupe trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06046131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing